AngioDynamics Inc. (UG2)
XDUS
Real-time Data
06:00 AM
Day's Range
12.9052 wk Range
8.10Overview - UG2 - AngioDynamics Inc.
Key Statistics
Valuation
P/E (Trailing)
‪-15.11‬
PEG Ratio
‪-0.18‬
Price / Book
‪3.24‬
Profitability
Gross Margin
‪54.00%‬
Profit Margin
‪54.62%‬
Operating Margin
‪-6.97%‬
Return on Assets
‪-13.75%‬
Return on Equity
‪-21.50%‬
Ownership
Shares Outstanding
41.70M
Price stats
50-Day Avg
‪12.80‬
200-Day Avg
‪10.52‬
Peers - UG2 - AngioDynamics Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on XDUS.
- UG2XDUSAngioDynamics Inc.+33.08%52-week change-15.11P/E (Trailing)‪54.62%‬Profit Margin
- A5IXDUSAtriCure Inc.+38.94%52-week change258.89P/E (Trailing)‪1.85%‬Profit Margin
- 6L8XDUSPulse Biosciences Inc+60.65%52-week change-40.00P/E (Trailing)‪-54.00%‬Profit Margin
- 5FRXDUSMenicon Co., Ltd.+37.06%52-week change0.15P/E (Trailing)‪53.81%‬Profit Margin
- RGNXDUSRepligen Corporation+35.69%52-week change189.31P/E (Trailing)‪52.31%‬Profit Margin
- BJX1XDUSBioLife Solutions Inc.+32.73%52-week change-366.67P/E (Trailing)‪64.56%‬Profit Margin
- WPSXDUSWest Pharmaceutical Services Inc.+32.06%52-week change47.45P/E (Trailing)‪35.91%‬Profit Margin
Profile Summary - UG2 - AngioDynamics Inc.
About
AngioDynamics Inc. is a medical technology company that develops, manufactures, and markets minimally invasive medical devices for healthcare providers. Its product portfolio supports image-guided procedures across vascular intervention, vascular access, oncology, and surgical care, with devices used to treat…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
